Northeast China’s Heilongjiang Province is set to implement a vaccination subsidy initiative in 2026, providing free doses of specific vaccines to eligible residents.The program includes several key measures:- Free administration of the second dose of the recombinant herpes zoster vaccine (CHO cell) for residents aged 50 and above;- Free final dose of the 9-valent HPV vaccine for females aged 9-26 and 35-45, as well as for males aged 16-26;- Free doses of the bivalent HPV vaccine, specifically the second dose for females aged 9-14, and both the second and third doses for those aged 15-45;- And free nationally planned bivalent HPV vaccination for girls who have reached 13 years of age on or after November 10, 2011.The initiative is projected to cover subsidy for more than 100,000 vaccine doses.
